The Effect of a Multi-Component Nutraceutical Supplement on Dyslipidemia, Glycemic Control, and Blood Pressure: A Preliminary Prospective Observational Pilot Study
Early metabolic abnormalities, including borderline dyslipidemia, mildly elevated blood pressure, and impaired glycemic control, are associated with increased cardiometabolic risk. This study aimed to explore whether a multi-component nutraceutical formulation, CARDIO360, was associated with favorable changes in li...